These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 24108069)

  • 21. Late development of a lamellar macular hole after the spontaneous separation of vitreoretinal traction: case report.
    Rodríguez A; Rodríguez FJ; Valencia M; Castaño C
    Eur J Ophthalmol; 2016 Nov; 26(6):e168-e170. PubMed ID: 27445071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphological Reconstitution and Persistent Changes After Intravitreal Ocriplasmin for Vitreomacular Traction and Macular Hole.
    Zandi S; Freiberg F; Vaclavik V; Pfister IB; Traine PG; Kaya C; Michels S; Garweg JG
    J Ocul Pharmacol Ther; 2020 Mar; 36(2):126-132. PubMed ID: 31934816
    [No Abstract]   [Full Text] [Related]  

  • 23. Oct-based interpretation of the vitreomacular interface and indications for pharmacologic vitreolysis.
    Stalmans P; Duker JS; Kaiser PK; Heier JS; Dugel PU; Gandorfer A; Sebag J; Haller JA
    Retina; 2013; 33(10):2003-11. PubMed ID: 23881226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The epidemiology of vitreoretinal interface abnormalities as detected by spectral-domain optical coherence tomography: the beaver dam eye study.
    Meuer SM; Myers CE; Klein BE; Swift MK; Huang Y; Gangaputra S; Pak JW; Danis RP; Klein R
    Ophthalmology; 2015 Apr; 122(4):787-95. PubMed ID: 25556116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocriplasmin for symptomatic vitreomacular adhesion.
    Neffendorf JE; Kirthi V; Pringle E; Jackson TL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD011874. PubMed ID: 29040800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PNEUMATIC VITREOLYSIS VERSUS PARS PLANA VITRECTOMY IN FOCAL SYMPTOMATIC VITREOMACULAR TRACTION SYNDROME: A Randomized Trial.
    Kumar V; Sonkar R; Verma S; Azad SV; Chawla R; Venkatesh P; Vohra R; Kumar A
    Retina; 2022 Jul; 42(7):1277-1283. PubMed ID: 35723920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of intravitreal ocriplasmin treatment for vitreomacular traction in clinical practice.
    Schumann RG; Langer J; Compera D; Luedtke K; Schaumberger MM; Kreutzer T; Mayer WJ; Wolf A; Priglinger SG
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2081-2089. PubMed ID: 28755165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rate and timing of spontaneous resolution in a vitreomacular traction group: should the role of watchful waiting be re-evaluated as an alternative to ocriplasmin therapy?
    Dimopoulos S; Bartz-Schmidt KU; Gelisken F; Januschowski K; Ziemssen F
    Br J Ophthalmol; 2015 Mar; 99(3):350-3. PubMed ID: 25342274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ocriplasmin as a treatment option for symptomatic vitreomacular traction with and without macular hole. First clinical experiences].
    Maier M; Abraham S; Frank C; Feucht N; Lohmann CP
    Ophthalmologe; 2015 Dec; 112(12):990-4. PubMed ID: 26062717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole.
    Duker JS; Kaiser PK; Binder S; de Smet MD; Gaudric A; Reichel E; Sadda SR; Sebag J; Spaide RF; Stalmans P
    Ophthalmology; 2013 Dec; 120(12):2611-2619. PubMed ID: 24053995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravitreal ocriplasmin: A breakthrough in the treatment of vitreomacular traction?
    Mec-Słomska AE; Adamiec-Mroczek J; Kuźmicz E; Misiuk-Hojło M
    Adv Clin Exp Med; 2017; 26(3):527-531. PubMed ID: 28791829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macular hole formation and spontaneous closure after vitrectomy for vitreomacular traction documented in spectral-domain optical coherence tomography.
    Odrobina D; Laudańska-Olszewska I; Gozdek P; Maroszyński M; Amon M
    BMC Ophthalmol; 2014 Feb; 14():17. PubMed ID: 24552161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of the 2-Year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) Randomized Trial.
    Dugel PU; Tolentino M; Feiner L; Kozma P; Leroy A
    Ophthalmology; 2016 Oct; 123(10):2232-47. PubMed ID: 27499517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anatomical and functional prognosis of secondary retinal detachments after sutureless macular surgery].
    Matonti F; Meyer F; Rouhette H; Guigou S; Dumas S; Parrat E; Mérité PY; Pommier S
    J Fr Ophtalmol; 2014 Jan; 37(1):58-63. PubMed ID: 24210934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocriplasmin-Induced Macular Hole Closure in the Absence of Vitreomacular Adhesion Release.
    Modi YS; Singh RP
    Ophthalmic Surg Lasers Imaging Retina; 2015 Jun; 46(6):677-9. PubMed ID: 26114851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expanding spectrum of vitreomacular traction.
    Shechtman DL; Dunbar MT
    Optometry; 2009 Dec; 80(12):681-7. PubMed ID: 19932441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocriplasmin Treatment Leads to Symptomatic Vitreomacular Adhesion/Vitreomacular Traction Resolution in the Real-World Setting: The Phase IV ORBIT Study.
    Khanani AM; Duker JS; Heier JS; Kaiser PK; Joondeph BC; Kozma P; Rosberger DF; MacCumber M; Boyer DS; Pieramici DJ
    Ophthalmol Retina; 2019 Jan; 3(1):32-41. PubMed ID: 30935657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Traction maculopathies--pathogenesis and diagnostics].
    Wylegała E; Woyna-Orlewicz A; Piłat J; Teper S; Ludyga A
    Klin Oczna; 2006; 108(10-12):457-63. PubMed ID: 17455727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From the analysis of pharmacologic vitreolysis to the comprehension of ocriplasmin safety.
    Morescalchi F; Gambicorti E; Duse S; Costagliola C; Semeraro F
    Expert Opin Drug Saf; 2016 Sep; 15(9):1267-78. PubMed ID: 27388220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diseases of the vitreo-macular interface].
    Koerner F; Garweg J
    Klin Monbl Augenheilkd; 1999 May; 214(5):305-10. PubMed ID: 10420374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.